Table 3. Characterization of FRDA patients.
Patient | Age of Onset (years) | Interval between I and II a |
---|---|---|
F10 | 11 | 7 y, 9 mo |
F11 | 14 | 7 y, 4 mo |
F12 | 20 | 8 y, 3 mo |
M7 | 10 | 8 y, 8 mo |
F13 | 16 | 7 y, 4 mo |
a Repeated blood samplings (I and II) were performed at the intervals indicated in the table.